Di bawah ada daftar dengan kolom dan profil perusahaan yang subyeknya berkaitan.

Berita Hari Ini Healthcare

  • Indonesia's National Health Insurance Program: Rising Financial Mismatch

    There is a growing mismatch between claims paid and premiums received by Indonesia's Healthcare and Social Security Agency (Badan Penyelenggara Jaminan Sosial, or BPJS Kesehatan). This year the deficit could reach IDR 9.8 trillion (approx. USD $731 million), leading to concern about the financial sustainability of the program and the need to search for additional and innovative ways to fund Indonesia's National Health Insurance (Jaminan Kesehatan Nasional, or JKN) program.

    Lanjut baca ›

  • Layanan Kesehatan Indonesia: Meningkatkan Produksi Lokal Bahan Baku Obat

    Salah satu paket stimulus ekonomi selanjutnya dari Pemerintah Indonesia akan berfokus pada meningkatkan produksi dalam negeri bahan baku untuk obat-obatan dan perangkat medis. Saat ini, industri tersebut masih sangat tergantung pada impor bahan baku. Diperkirakan bahwa sekitar 90% dari bahan baku/dasar untuk pembuatan obat-obatan dan perangkat medis perlu diimpor dari luar negeri sehingga menyebabkan tekanan tambahan pada neraca pembayaran Indonesia.

    Lanjut baca ›

  • Mergers and Acquisitions (M&A) in Indonesia Expected to Rise in 2016

    RSM Indonesia, one of Indonesia's leading audit, tax and financial advisory firms, expects to see more mergers and acquisitions (M&A) in Indonesia in 2016 due to the improving global and domestic economic conditions, a stable rupiah exchange rate, and Indonesian's growing purchasing power. For foreign investors a M&A deal is one of the strategies to enter Indonesia. Up to early November, the total value of M&A deals in Indonesia in 2015 stood at USD $3.53 billion.

    Lanjut baca ›

  • Shareholders Mitra Keluarga Karyasehat Approve 10:1 Stock Split

    On the latest shareholder meeting (conducted Wednesday 23 September) it was decided that Indonesian hospital operator Mitra Keluarga Karyasehat can go-ahead with its planned 10:1 stock split. The company wants to reduce its shares’ nominal value by ten in order to boost liquidity as shares become more affordable. Meanwhile, shareholders also agreed to boost the company’s paid up capital. After Siloam International Hospitals, Mitra Keluarga Karyasehat is Indonesia’s second-largest hospital operator.

    Lanjut baca ›

  • UNICEF: Indonesia’s Child Mortality Rate Has Fallen Substantially since 1990

    The United Nations Children's Fund (UNICEF) stated in a recently published report that Indonesia has made significant progress in reducing the country’s child mortality rate. According to the report, entitled “Committing to Child Survival: A Promise Renewed (Progress Report 2015)", Indonesia’s mortality rate for children below the age of five years currently stands at 27 deaths per 1,000 births, a significant improvement from the 85 deaths per 1,000 births that was recorded in 1990.

    Lanjut baca ›

  • Perusahaan Farmasi Merck Indonesia Merencanakan Stock Split di 2015

    Perusahaan farmasi Indonesia Merck, yang dikontrol oleh perusahaan jasa kesehatan konsumen dari Jerman Merck Holding GmbH, merencanakan untuk melaksanakan stock split pada tahun 2015 dalam usaha meningkatkan likuiditas dan perdagangan saham perusahaannya. Merck pada saat ini mendiskusikan rencana tersebut dengan Bursa Efek Indonesia dan Otoritas Jasa Keuangan (OJK). Bambang Nurcahyo, Direktur Keuangan Merck, mengatakan bahwa rasio ideal untuk rencana stock split ini adalah 1:20. Sebuah rapat umum pemegang saham akan diadakan pada pertengahan 2015.

    Lanjut baca ›

  • IPO Mitra Keluarga Karyasehat on the Indonesia Stock Exchange

    On Tuesday (24/03), Indonesian hospital operator Mitra Keluarga Karyasehat became the second company to list on the Indonesia Stock Exchange (IDX) in 2015. It turned out to be a highly successful initial public offering (IPO) as the company’s shares surged 24.7 percent on its trading debut, reflecting investors’ solid confidence in healthcare stocks. Mitra Keluarga, subsidiary of pharmaceutical company Kalbe Farma, raised IDR 4.4 trillion (USD $341 million), hence constituting the largest IPO since Garuda Indonesia’s IPO in 2011.

    Lanjut baca ›

  • Shares of Indonesia’s Kalbe Farma Hurt by Fatal Medicine Scandal

    Shares of Kalbe Farma, Indonesia’s largest pharmaceutical company, have been under pressure over the past couple of days due to the deaths of two hospital patients after they had taken a medicine manufactured by Kalbe Farma. According to the Indonesian Pharmacy Association (GP Farmasi Indonesia) Buvanest Spinal, an anesthetic, was wrongly packaged and hence did not contain bupivacaine but instead tranexamic acid, which aims to stop or reduce heavy bleeding (usually used during surgery).

    Lanjut baca ›

  • Indonesia’s Capital City Jakarta at Bottom of Safe Cities Index 2015

    In the Safe Cities Index 2015, launched by the Economist Intelligence Unit (EIU), Indonesia’s capital city of Jakarta is ranked at the bottom of the index. The Safe Cities Index, which covers 50 large cities worldwide (selected on factors which include regional representation and availability of data), based its ranking on an average score across four categories: digital security, health security, infrastructure safety and personal safety. In 2014, data from the Jakarta Police showed that 213 out of every 100,000 Jakartans were victims of various crimes.

    Lanjut baca ›

  • Jokowi Raises Indonesia’s Subsidized Fuel Prices by IDR 2,000/Liter

    After weeks of uncertainty, Indonesian President Joko Widodo announced on Monday (17/11) that prices of subsidized fuels (gasoline and diesel) are to be raised by IDR 2,000 (USD $0.16) per liter starting from midnight. Gasoline (premium) is to be raised from IDR 6,500 to IDR 8,500 per liter, while diesel will be raised from IDR 5,500 to IDR 7,500 per liter. Earlier it was speculated that an IDR 3,000 per liter price hike would be announced. However, as global oil prices have declined sharply, this was considered an unnecessary burden for the people.

    Lanjut baca ›

Artikel Terbaru Healthcare

  • Universal Health Coverage in Indonesia; Finding a Solution to BPJS Kesehatan’s Widening Deficit

    At the start of 2014 the government of Indonesia launched its ambitious universal health coverage (UHC) program. This program aims to ensure that all Indonesians (whether rich or poor) have access to health services (of sufficient quality), while also ensuring that the Indonesian people do not suffer financial hardship when paying for these health services. In other words, the program aims to deliver affordable healthcare to all citizens.

    Lanjut baca ›

  • Developing Upstream Facilities in Indonesia's Pharmaceutical Industry

    Vincent Harijanto, Head of the Indonesian Pharmaceutical Association (GP Farmasi) business development committee, said about 95 percent of raw materials used in Indonesia's pharmaceutical industry need to be imported from abroad. This dependence on imports causes several problems, for example prices of pharmaceutical products are relatively high on the Indonesian market, while Indonesian pharmaceutical companies (and Indonesian consumers) can suddenly face rising prices in times of rupiah depreciation.

    Lanjut baca ›

  • Difficult for Indonesia to Become an Innovation-Driven Economy

    A new report shows Indonesia lacks behind its regional peers in terms of innovation. This is a concern because it means Indonesia's workforce is not equipped with the skills, knowledge or health that are necessary to be innovation-driven. Therefore, the Indonesian government needs to remain focused on enhancing the quality of education and healthcare. Innovation is widely regarded as a driver of economic growth and development.

    Lanjut baca ›

  • Pharmaceutical Exports Indonesia Remain Under Pressure in 2017

    Exports of pharmaceutical products from Indonesia have declined due to increasing competition from China on the international market. Chinese pharmaceutical companies dominate export markets supported by China's low production cost environment and the availability of raw materials at home. However, despite this situation, the Indonesian Pharmacy Association (GP Farmasi Indonesia) remains optimistic that Indonesia's pharmaceutical exports can climb in 2017.

    Lanjut baca ›

  • Indonesian Pharmaceutical Companies in Focus: Kimia Farma

    State-controlled pharmaceutical company Kimia Farma is expected to show steadily improving corporate earnings in the years ahead supported by Indonesia's universal healthcare scheme (in Indonesian: Jaminan Kesehatan Nasional or JKN) that was implemented by the social security agency Badan Penyelenggara Jaminan Sosial Kesehatan (BPJS) in early 2014. The scheme aims to provide all Indonesian citizens with access to a wide range of health services. Obviously, local pharmaceutical companies are in a great position to benefit from this program.

    Lanjut baca ›

  • Hospital Sector Indonesia: Opportunities and Challenges

    Although Indonesia's National Health Insurance program is not without problems, it does benefit Indonesian hospitals and makes investment in the nation's hospital sector attractive, particularly as the Indonesian government targets to provide universal health care to all Indonesians by the year 2019. Reportedly, those hospitals that receive patients that fall under Indonesia's Healthcare and Social Security Agency (Badan Penyelenggara Jaminan Sosial, or BPJS Kesehatan) are the busiest hospitals in Indonesia at the moment.

    Lanjut baca ›

  • Pharmaceutical Industry Indonesia: Plagued by Weak Rupiah

    Companies active in the pharmaceutical industry of Indonesia need to find strategies to overcome sharp rupiah depreciation. Indonesia’s pharmaceutical industry is still - to a large extent - dependent on the import of raw materials, hence a weakening rupiah raises the costs of imports thus eroding profit margins. Since May 2013, when the US Federal Reserve started to hint at monetary tightening, the US dollar has experienced bullish momentum. Between the May 2013 and July 2015, the rupiah depreciated around 37 percent against the US dollar.

    Lanjut baca ›

  • Malnutrition in Indonesia: 8.4 Million Children Stunted!

    A new World Bank report, entitled “The Double Burden of Malnutrition in Indonesia”, says that 37.2 percent of Indonesian children under the age of five - or 8.4 million children - are stunted (meaning excessively small for their age) and suffer from chronic malnutrition. As such, Indonesia has the fifth-highest level of stunting in the world. The report also states that 19.6 percent of Indonesian children under five years old (approximately 4.4 million) are underweight as a result of malnutrition. Public awareness about this issue is low in Indonesia.

    Lanjut baca ›

  • Penawaran Umum Perdana di Indonesia: Mitra Keluarga Karyasehat

    Mitra Keluarga Karyasehat, operator rumah sakit dan unit usaha dari Grup Kalbe, menargetkan untuk meraup Rp 4,2 trilliun dalam penawaran umum perdana (IPO) di Bursa Efek Indonesia (BEI) pada Maret 2015. Perusahaan ini akan menawarkan 261,9 juta saham, setara dengan 18% dari modal ditempatkan dan disetor penuh perseroan. Lima persen dari total saham ini adalah saham baru, sementara 13% adalah saham didivestasi private equity firm Lion Investment Partners.

    Lanjut baca ›